Anti-ECE-2 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the cytoplasmic domain of human ECE-2, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
O60344
Size
100ug
Cat. #
RP1ECE2

In stock

SKU
RP-ECE2

Options

As low as: $130.00

Target Overview

Endothelin-converting enzyme 2 (ECE-2, EC 3.4.24.71) is a membrane-bound zinc metalloprotease that catalyzes the proteolytic conversion of big endothelin peptides to their active vasoconstrictor forms. ECE-2 belongs to the M13 neprilysin family of peptidases and shares structural and catalytic features with the related enzyme ECE-1, though it exhibits distinct tissue distribution and substrate preferences. The enzyme is expressed primarily in neural tissues and has been localized to intracellular compartments including the trans-Golgi network and endosomal vesicles. Beyond endothelin processing, ECE-2 has been implicated in regulating the trafficking and signaling of G protein-coupled receptors, including the κ opioid receptor. Recent studies have identified roles for ECE-2 in cancer progression, particularly in non-small cell lung cancer where it participates in ET1/YAP1-mediated oncogenic signaling. The protein is encoded by the ECE2 gene (UniProt O60344) and exists as a type II transmembrane protein with an extracellular catalytic domain and a short cytoplasmic N-terminal tail.

Background

ECE-2 functions as a key regulator of endothelin peptide bioavailability, cleaving big endothelin-1, -2, and -3 at a conserved Trp21-Val/Ile22 bond to generate the mature vasoactive peptides. While ECE-1 is the predominant isoform in vascular endothelium, ECE-2 shows preferential expression in neural tissues and the central nervous system, where it may contribute to local endothelin production and neuropeptide processing. The enzyme operates optimally at acidic pH, consistent with its localization to acidic intracellular compartments, distinguishing it from the neutral-pH-optimized ECE-1. Recent work has expanded the functional repertoire of ECE-2 beyond endothelin metabolism. Gupta et al. (2025) demonstrated that ECE-2 regulates κ opioid receptor trafficking and signaling, revealing a novel role in opioid receptor biology independent of its peptidase activity. In oncology, Xiao et al. (2025) identified ECE-2 as a driver of non-small cell lung cancer progression through an ET1/YAP1/MAGEA3 signaling axis, suggesting that ECE-2-mediated endothelin-1 production promotes tumor growth via Hippo pathway modulation. These findings position ECE-2 as a potential therapeutic target in both pain modulation and cancer biology. The ECE2 gene can also participate in a readthrough transcript with the upstream EEF1AKMT4 gene, producing a fusion protein of uncertain function. Triple Point Biologics offers four rabbit polyclonal antibodies raised against the cytoplasmic domain of ECE-2, providing researchers with tools to investigate enzyme expression, localization, and regulation across diverse experimental systems.

References

  1. Gupta A et al (2025) Endothelin-converting enzyme 2 regulates κ opioid receptor trafficking and function. J Pharmacol Exp Ther. PubMed · doi:10.1016/j.jpet.2025.103750
  2. Xiao H et al (2025) Identification of ECE2 signaling in promoting non-small lung cancer progression through ET1/YAP1/MAGEA3 axis. Sci Rep. PubMed · doi:10.1038/s41598-025-90159-0
  3. Shaji A et al (2024) Identification of potential differences in salivary proteomic profiles between estrus and diestrus stage of estrous cycle in dairy cows. Syst Biol Reprod Med. PubMed · doi:10.1080/19396368.2024.2370328
  4. Ling L et al (2024) Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling. J Gene Med. PubMed · doi:10.1002/jgm.3571

Additional Specifications

Size 100 µg
Gene Symbol ECE2
UniProt ID O60344
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Cytoplasmic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-106.
Immunogen (Stem Region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 87-106.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 139-811.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 761-811.
Alternate Names Endothelin-converting enzyme 2, EC 3.4.24.71, EEF1AKMT4-ECE2 readthrough transcript protein, Endothelin-converting enzyme-2

Frequently Asked Questions

What is the expected molecular weight for ECE-2 on Western blot?

ECE-2 typically migrates at approximately 95-105 kDa on Western blot, reflecting the full-length membrane-bound glycoprotein. The mature enzyme contains N-linked glycosylation sites that contribute to heterogeneity in apparent molecular weight. In some lysates you may observe additional bands corresponding to differentially glycosylated forms or proteolytic fragments. Treatment with PNGase F can help confirm glycosylation status if band complexity is an issue. Always include a positive control lysate from ECE-2-expressing tissue or transfected cells, as endogenous expression levels vary considerably across cell types.

What dilution should I start with for ECE-2 Western blot?

We recommend starting at 1:1000 dilution for Western blot with this rabbit polyclonal ECE-2 antibody, which has been validated at that concentration. For low-expressing samples, you may need to increase antibody concentration to 1:500 or increase protein load per lane to 40-50 µg. Neural tissue lysates typically give stronger signals than peripheral tissues due to ECE-2 expression patterns. Optimize blocking conditions using five percent non-fat milk or BSA in TRIS-buffered saline with Tween-20, and expect overnight incubation at four degrees Celsius to yield best results.

Does ECE-2 antibody cross-react with ECE-1?

ECE-1 and ECE-2 share approximately 60 percent sequence identity and belong to the same metalloprotease family, raising concerns about cross-reactivity. This antibody was raised against ECE-2-specific epitopes, but we recommend including parallel samples with ECE-1 knockout or knockdown controls if both enzymes are expressed in your system. ECE-1 migrates at similar molecular weight, so distinguishing them by size alone is unreliable. If you are working in tissues where both are abundant, consider using lysates from cells overexpressing each isoform individually to assess specificity under your exact experimental conditions.

Is this ECE-2 antibody suitable for detecting mouse or rat ECE-2?

This antibody has been validated for human ECE-2. Cross-reactivity with mouse and rat ECE-2 is predicted based on sequence homology in the immunogen region, but has not been formally validated by us. Human and rodent ECE-2 share high conservation in the catalytic and structural domains. If you are working with mouse or rat samples, we recommend testing the antibody at the suggested 1:1000 dilution initially, but include appropriate positive controls such as transfected cell lysates or tissues known to express ECE-2. Confirm specificity with blocking peptide or siRNA knockdown controls in your target species.

What sample preparation is best for detecting intracellular ECE-2?

ECE-2 localizes primarily to the trans-Golgi network and endosomal compartments rather than the plasma membrane, so total cell lysis protocols work well. Use RIPA buffer or similar detergent-containing lysis buffer with protease inhibitors to efficiently extract membrane-associated ECE-2. Avoid harsh sonication that may degrade the protein. For immunofluorescence applications, fix cells with four percent paraformaldehyde and permeabilize with 0.1-0.5 percent Triton X-100 to allow antibody access to intracellular compartments. Subcellular fractionation can enrich ECE-2 in membrane fractions if you are working with low-abundance samples.

What positive control tissue should I use for ECE-2 expression?

ECE-2 is expressed primarily in neural tissues, with brain lysates serving as a reliable positive control for Western blot validation. Within the brain, expression is particularly enriched in regions involved in pain and reward pathways. Human brain-derived cell lines or primary neuronal cultures are suitable alternatives if whole tissue lysates are unavailable. For non-neural applications, consider HEK293 or other mammalian cells transiently transfected with ECE-2 expression constructs. Endogenous ECE-2 levels are generally low in most peripheral tissues and immortalized cell lines, so negative results should be interpreted cautiously without a validated positive control.

How should I store this ECE-2 antibody for long-term stability?

Store the antibody at minus twenty degrees Celsius for routine use up to six months. For longer-term storage beyond six months, aliquot upon arrival and store at minus eighty degrees Celsius to preserve activity through multiple freeze-thaw cycles. Avoid repeated freeze-thaw cycles, as rabbit polyclonal antibodies can lose titer and increase background with each cycle. If you use the antibody frequently, keep a working aliquot at four degrees Celsius with 0.02-0.05 percent sodium azide as preservative for up to one month. Do not store in frost-free freezers, as temperature cycling degrades antibody performance over time.

Can I use this antibody for immunohistochemistry on ECE-2 in tissue sections?

This antibody is suitable for immunohistochemistry, though specific validation for ECE-2 IHC has not been completed in our facility. For paraffin-embedded sections, antigen retrieval is typically essential because ECE-2 epitopes can be masked by fixation. Try citrate buffer pH 6.0 with heat-induced epitope retrieval as a starting point. ECE-2 localizes intracellularly, so ensure adequate permeabilization during your staining protocol. Start with antibody dilution around 1:100 to 1:200 for IHC, which is more concentrated than Western blot applications. Include appropriate blocking steps and negative controls using adjacent sections with primary antibody omitted or preabsorbed with blocking peptide.

Validation imagery coming soon

Western blot validation figures for RP-ECE2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • Endothelin-converting enzyme 2
  • EC 3.4.24.71
  • EEF1AKMT4-ECE2 readthrough transcript protein
  • Endothelin-converting enzyme-2
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →